Preserving the Ocular Surface: Practice Pearls—Part IV

0.75 CME
$0 FEE
Preserving the Ocular Surface OG Image Size


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by educational grants from Alcon Laboratories, Inc.; Allergan, Inc.; Bausch + Lomb; Kala Pharmaceuticals; and Shire.

Target Audience

The intended audience for the activity is comprehensive ophthalmologists and other health care professionals involved in the treatment of patients with ocular surface disease (OSD).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Summarize new methods to diagnose and monitor ocular surface disorders.
  • Evaluate new and emerging modalities for the treatment of ocular surface disorders.
  • Describe the mechanisms of action of therapies used to treat ocular surface disorders.
  • Assess the rationale for treatment selection for ocular surface disorders based on patient presentation.

Activity Chair

Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC


Preeya K. Gupta, MD
Associate Professor of Ophthalmology
Duke University School of Medicine
Cornea & Refractive Surgery
Clinical Director
Duke Eye Center
Durham, NC

Edward J. Holland, MD
Director, Cornea Services, Cincinnati Eye Institute
Professor of Clinical Ophthalmology, University of Cincinnati
Cincinnati Eye Institute
Edgewood, KY

Francis S. Mah, MD
Director, Cornea Service
Co-Director, Refractive Surgery
Scripps Clinic
La Jolla, CA


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, April 4, 2019 through April 3, 2020.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the CME posttest and evaluation. Provide only one (1) answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty report the following relationship(s)

Preeya K. Gupta, MD
Consulting Fee: Alcon, Allergan, Aurea, Bio-Tissue, Johnson & Johnson Vision, Kala, NovaBay, Ocular Science, Shire, Sight Sciences, TearLab, TearScience, Zeiss

Edward J. Holland, MD
Consulting Fee: Aerie, Azura, Glaukos, Katena, Kala, Mati, Novartis, Omeros, Precision Lens, TearLab, Senju, Shire, Sight Sciences, SightLife Surgical, Vomaris
Speakers Bureau: Novartis, Omeros, Senju, Shire
Contracted Research: Mati, Novartis, Omeros, Senju

Terry Kim, MD
Consulting Fee: Aerie, Alcon/Novartis, Allergan/Actavis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Ocunexus Therapeutics, Kala, NovaBay, Ocular Therapeutix, Omeros, PowerVision, Presbyopia Therapies, Shire, SightLife Surgical, Silk Technologies, Simple Contacts, TearLab, TearScience
Ownership Interest: Kala, NovaBay, Ocular Therapeutix, Omeros, SightLife Surgical, Simple Contacts, TearScience

Francis S. Mah, MD
Consulting Fee: Aerie, Alcon/Novartis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Oculonexus, Dompe, EyePoint, Invirsa, iView, Kala, Mallinckrodt, NovaBay, Ocular Science, Ocular Therapeutix, Okogen, Omeros, PolyActiva, RxSight, Shire, Sun, Sydnexis, TearLab

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at